Academia Sinica yesterday approved the resignation of distinguished research fellow Chen Ching-shih (陳慶士) after news of research misconduct in eight of his published papers was made public by the Ohio State University, where he previously served as a cancer researcher.
Academia Sinica said in a statement that it is sorry to hear about the incident, but added that Chen’s misconduct occurred before he became head of Academia Sinica’s Institute of Biological Chemistry in August 2014.
The institution’s Research Ethics Committee would still look into work he performed while serving at the academy, the statement added.
Chen’s resignation from the Academia Sinica comes after academic journal Science and the university issued separate reports on Friday regarding the findings of research misconduct that led to his resignation as a cancer researcher from the university last year.
The reports said the investigation found Chen had “intentionally committed research misconduct” in 14 instances in eight journal articles, and was guilty of “deviating from the accepted practices of image handling and figure generation and intentionally falsifying data.”
Chen admitted to the charges and resigned in September last year, the university said.
The university said it has requested an “immediate retraction” of the papers, published between 2006 and 2014, that contain the fabricated data.
However, the implications of the misconduct go beyond unreliable academic papers, as Chen’s work had raised millions of US dollars in funding and led to multiple patents and the establishment of two compounds in clinical trials.
The university said it immediately shut down a clinical trial of one of Chen’s anti-cancer agents that Arno Therapeutics Inc had been conducting after obtaining exclusive rights to test the agents.
A spokesperson for the company said that issues with Chen’s papers had “zero impact” on its drug development efforts, Science said.
The university said it “hired an external consultant who validated that Chen’s research misconduct did not affect the Arno licensed compounds developed in his lab.”
“Patient safety was never compromised,” the university’s statement said.
The university said it has forwarded the investigation to federal authorities, meaning Chen could continue to be investigated for his actions.
Academia Sinica first became aware of the matter about a year ago, but it had limited access to Chen’s questionable articles because the university did not reveal its investigation on its Web site until Friday, Academia Sinica Central Academic Advisory Committee executive secretary Henry Sun (孫以瀚) said yesterday.
This is the worst punishment a Taiwanese academic has ever received from a foreign institution, dealing a heavy blow to the nation’s image in international academia, Sun said.
Sun quoted Chen as saying that his laboratory staff “beautified” data to make their research look better, and that he was responsible for lax supervision.
Yesterday morning, Chen’s profile was accessible on the Institute of Biological Chemistry’s Web site, but it was later taken down after Chen tendered his verbal resignation to Academia Sinica president James Liao (廖俊智).
Meanwhile, China Medical University, where Chen in February temporarily served as the director of its Institute of New Drug Development, yesterday said it is unclear about the matter and is collecting information about the case.
Before Chen returned to Taiwan to serve as director of the Institute of Biological Chemistry in August 2014 — a position he held until August last year — he had taught at the Ohio State University’s College of Pharmacy, the University of Rhode Island and the University of Kentucky.
Specializing in medicinal chemistry, cancer studies, biological chemistry and translational medicine, Chen has received research awards from the US Prostate Cancer Foundation and the Hearst Foundation, and is a fellow at the American Association for the Advancement of Science.
In April last year, he and National Cheng Kung University researchers found a relation between vitamin E and cancer prevention, and created an anti-tumor agent that is 20 times more efficient than previous ones, which was then considered a potential opportunity to develop a new anti-cancer drug.
‘FREEDOM WINE’: Taiwanese are empathetic of Australians, the president said, while lawmakers called on their constituents to drink Australian wine to show their support Taiwan would take action to back Australians at a time when they are “under tremendous pressure,” President Tsai Ing-wen (蔡英文) said yesterday, as tensions between Australia and China heated up. Taipei and Canberra have been mutually supportive in fighting the COVID-19 pandemic, especially in exchanging critical medical materials in the early stages, Tsai said, before chairing the Democratic Progressive Party (DPP) Central Standing Committee meeting in Taipei. Taiwan and Australia are like-minded nations, sharing the common values of democracy, freedom and human rights, while their economic and trade relations have also become close, she said. Canberra has been voicing support for Taiwan’s international
VIGILANCE: From tomorrow all arrivals must provide the result of a PCR test issued within three days of boarding, and the CECC asked people to report anyone who has faked their result The Central Epidemic Command Center (CECC) expects an increase in the number of returning travelers in the coming days, Minister of Health and Welfare Chen Shih-chung (陳時中) said yesterday, adding that the varying qualities of COVID-19 polymerase chain reaction (PCR) test reports from other countries is a big concern. Chen, who heads the center, was speaking to the media on the sidelines of a Taiwan Foundation for Rare Disorders scholarship award ceremony in Taipei. “As the global COVID-19 situation is worsening, and with some holidays coming up, there might be an increase in the number of overseas Taiwanese returning to Taiwan,” he
CECC RULES: The autumn-winter COVID-19 prevention program, including mandatory mask wearing in eight types of public venues and indoor facilities, begins today A temporary, two-week ban on Indonesian migrant workers entering the nation is to begin on Friday, the Central Epidemic Command Center (CECC) announced yesterday as it reported 24 new imported cases of COVID-19. Twenty of the new cases are Indonesian migrant workers who arrived between Nov. 11 and Friday last week, said Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center. The cases were discovered during a special project on Friday to conduct polymerase chain reaction (PCR) tests on all 939 recently arrived Indonesian migrant workers in centralized quarantine facilities, as the majority of imported cases in the past
Passports with a redesigned cover highlighting Taiwan would be issued starting on Jan. 11, the Ministry of Foreign Affairs said yesterday. The new cover design, which was announced on Sept. 2, highlights Taiwan by printing the word in a larger font. While the new passport cover retains “the Republic of China” in Chinese, the English name is printed along the outer circle of the national emblem, which would enable other nations to clearly identify that it is a Taiwanese passport, not a Chinese passport, the ministry said. The costs and application procedures for the new version are the same as